Press Releases

Date	Title	Company
23-May-2023	BioSenic provides first quarter 2023 business update	BioSenic
23-May-2023	ABPI response to DHSC antimicrobial resistance research funding	ABPI
23-May-2023	Promising Phase 1 results for antibody NI006 in ATTR cardiomyopathy published in The New England Journal of Medicine	Neurimmune
23-May-2023	Two thirds of Brits would take part in a clinical trial to help discover new treatments - but financial payment is key	Lindus Health
23-May-2023	Europe Pelvic Floor Diagnostics Market is set to rise at a 7.8% CAGR \| Exclusive Report by FMI	MARKITWIRED
23-May-2023	Pelvic Floor Stimulators Market is estimated to grow at a CAGR of 8.8% during the forecast period ending in 2031	MARKITWIRED
23-May-2023	Ocular Drug Delivery System Market sales will total US$ 27.82 Billion by 2031 \| Says Future Market Insights	MARKITWIRED
23-May-2023	Necrotizing Fasciitis Treatment Market value worth US$ 4.6 Billion is projected for the industry by 2032 \| FMI	MARKITWIRED
23-May-2023	Dental Fluorescence Analyzer Market is anticipated to grow at a CAGR of 9% from 2022 to 2032	MARKITWIRED
23-May-2023	Aptamer Group consortium awarded Eurostars grant to develop a novel prenatal disease diagnostic device	Aptamer Group
23-May-2023	Alfa Chemistry’s Laboratory Increases Capability for Water Analysis, Resin Analysis, and Chromatography Analysis	Alfa Chemistry
23-May-2023	Marinomed Biotech AG reports best first quarter in company history	Marinomed Biotech AG
23-May-2023	Biosensors Market in South Korea is expected to reach a valuation of US$ 1.6 billion by 2032 Growing at a CAGR of 10.3%	MARKITWIRED
23-May-2023	Central Pain Syndrome Management Market to reach US$ 100 Billion by 2033, growing at a 5% CAGR: FMI Report	MARKITWIRED
23-May-2023	COVID-19 Vaccine Packaging and Delivery Devices Market is projected to reach a valuation of US$ 2.2 billion by 2033	MARKITWIRED
23-May-2023	Chronic Smell and Flavor Loss Market Is Expected to Register Growth at 6.4% CAGR through 2033- FMI Study	MARKITWIRED
23-May-2023	Hyperglycemia Treatment Market to grow at a 12.3% CAGR from 2023 to 2033, Insulin Therapy to be Most Common Treatment Approach: FMI Report	MARKITWIRED
23-May-2023	AEVIS VICTORIA SA – Increased revenues for the operational divisions, positive outlook for the current fiscal year. Organic growth of 9.2% in the first quarter 2023.	AEVIS VICTORIA SA
23-May-2023	Hyaluronic Acid Personal Care Products Market is estimated to reach US$ 7.36 billion by 2033	MARKITWIRED
23-May-2023	Personalized Medicine Market is projected to reach US$ 690.9 Billion by 2033 \| FMI Study	MARKITWIRED